Company description::
Recently, the FDA asked manufacturers of 10 antidepressant/SSRI drugs to add suicide-related warnings on their labels. Is this a rational move?
FDA has not found any significant scientific evidence that antidepressants can increase the risk of suicide. “Perhaps, the FDA’s decision was a political move — to appease the angry parents who might have concluded that the medications are to blame for their children's suicidal gesture,” says Dr. Rayel.
Indeed, this is a very difficult issue that FDA and the public should contend with. “Clinical depression in itself causes suicidality. Knowing the exact contribution of medication is not easy,” Dr. Rayel adds. Meanwhile scientific and public debate is necessary to resolve the issue.
Dr. Michael Rayel, author of First Aid to Mental Illness: A Practical Guide for Patients and Caregivers, has an expertise and experience that your listeners can benefit from. He is board certified in General, Forensic, and Geriatric Psychiatry. He’s also certified in Clinical Psychopharmacology by the American Society of Clinical Psychopharmacology.
For a stimulating interview with Dr. Rayel , e-mail Gayzelle at gamr@soardime.com.
|